Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary phospholipids, primarily consisting of phosphatidylcholine, are critical components of the gastrointestinal (GI) environment that serve both protective and digestive functions. They form a hydrophobic, surfactant-like layer on the surface of the mucus gel, which acts as a primary biophysical barrier against luminal aggressors such as gastric acid, bile salts, and digestive enzymes (Lichtenberger et al., 1995). In addition to barrier maintenance, these phospholipids are essential for the emulsification of dietary fats, facilitating their breakdown by pancreatic lipases and subsequent absorption in the small intestine (Dial et al., 2008). Clinical research has highlighted the importance of these molecules in inflammatory bowel diseases; for instance, patients with ulcerative colitis often exhibit a significant depletion of phosphatidylcholine in their colonic mucus, which correlates with increased disease activity (Ehehalt et al., 2010). Therapeutic strategies like delayed-release phosphatidylcholine (e.g., LT-02) are designed to replenish this lipid layer and restore mucosal integrity. Furthermore, the interaction between phospholipids and non-steroidal anti-inflammatory drugs (NSAIDs) is pharmacologically significant, as NSAIDs can disrupt this protective layer, leading to mucosal injury and ulceration (Lichtenberger et al., 2006).
Restoration of the mucosal hydrophobic barrier and emulsification of dietary fats.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary phospholipids.